4basebio PLC (AIM: 4BB)

4basebio Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.6	0.51	0.27	0.34	0.46	0.81
Revenue Growth (YoY)	68.36%	88.81%	-20.71%	-26.84%	-42.82%	-
Cost of Revenue	0.18	0.17	0.03	0.07	0.19	0.92
Gross Profit	0.42	0.34	0.24	0.27	0.27	-0.11
Selling, General & Admin	6.81	5.25	3.88	1.86	0.66	1.42
Research & Development	4.23	3.56	2.08	1.62	0.34	1.02
Other Operating Expenses	-0.43	-0.31	-0.06	0.32	-0.1	-0.89
Operating Expenses	10.62	8.51	5.91	3.8	0.9	1.54
Operating Income	-10.2	-8.17	-5.67	-3.53	-0.62	-1.66
Interest Expense	-0.55	-0.3	-0.09	-0.11	-0.09	-0.44
Currency Exchange Gain (Loss)	0.11	0.11	-0.17	-	-	-
EBT Excluding Unusual Items	-10.63	-8.35	-5.93	-3.64	-0.72	-2.09
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.02
Pretax Income	-10.63	-8.35	-5.93	-3.64	-0.72	-2.12
Income Tax Expense	-0.8	-0.69	-0.78	-0.41	0	-0.42
Net Income	-9.84	-7.67	-5.15	-3.24	-0.72	-1.69
Net Income to Common	-9.84	-7.67	-5.15	-3.24	-0.72	-1.69
Shares Outstanding (Basic)	13	12	12	12	9	9
Shares Outstanding (Diluted)	13	12	12	12	9	9
Shares Change (YoY)	1.59%	0.01%	-	37.05%	4.24%	-
EPS (Basic)	-0.79	-0.62	-0.42	-0.26	-0.08	-0.20
EPS (Diluted)	-0.79	-0.62	-0.42	-0.26	-0.08	-0.20
Free Cash Flow	-8.99	-7.05	-5.86	-3.62	-1.37	-1.09
Free Cash Flow Per Share	-0.72	-0.57	-0.48	-0.29	-0.15	-0.13
Gross Margin	69.63%	67.19%	89.18%	79.59%	59.31%	-13.86%
Operating Margin	-1711.58%	-1613.83%	-2115.30%	-1043.49%	-134.63%	-204.95%
Profit Margin	-1650.67%	-1514.82%	-1921.64%	-957.10%	-155.63%	-209.41%
Free Cash Flow Margin	-1507.55%	-1393.08%	-2186.19%	-1072.19%	-297.19%	-134.65%
EBITDA	-9.63	-7.6	-5.33	-3.35	-0.58	-1.57
EBITDA Margin	-	-	-	-	-125.54%	-194.55%
D&A For EBITDA	0.57	0.57	0.34	0.18	0.04	0.08
EBIT	-10.2	-8.17	-5.67	-3.53	-0.62	-1.66
EBIT Margin	-	-	-	-	-134.63%	-204.95%

Source: S&P Capital IQ. Standard template. Financial Sources.